Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness

BACKGROUND: Patients with cancer have an elevated risk of venous thromboembolism. Importantly, patients with cancer, who have metastatic disease, renal insufficiency, or are receiving anticancer therapy, have an even higher risk of a recurrent event. Similarly, the risk of recurrent venous thromboem...

Descripción completa

Detalles Bibliográficos
Autores principales: Dranitsaris, George, Shane, Lesley G, Woodruff, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262601/
https://www.ncbi.nlm.nih.gov/pubmed/28857713
http://dx.doi.org/10.1177/1078155217727140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262601/
https://www.ncbi.nlm.nih.gov/pubmed/28857713
http://dx.doi.org/10.1177/1078155217727140

Ejemplares similares